Research and experimental development on natural sciences and engineering
BIOSERGEN AS
Revenue 2024
NOK 75,000
Operating profit
NOK −10.0m
Equity
NOK 5.4m
Incorporated
2004
Share capital
NOK 4.3m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 75k | |
| Total operating costs | 10.1m | |
| Operating profit (EBIT) | −10.0m | |
| Net financial items | −423k | |
| Profit for the year | −10.4m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 21.8m | |
| of which current assets | 6.9m | |
| Equity | 5.4m | |
| Total liabilities | 16.4m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.